AIIMS Delhi to commence screening children from 6-12 years for Covaxin clinical trials
The All India Institute of Medical Sciences (AIIMS), New Delhi will on Tuesday commence the screening of children from the age group of 6 – 12 years for the clinical trials for the Hyderabad-based Bharat Biotech indigenously prepared Covid-19 vaccine Covaxin. “The selection process for the clinical trial of Covaxin among children in the age…